PGNYProgyny, Inc.
$34.84+87% 1Y
$34.84
$16.3052 weeks$34.84
Latest close: a new 52-week highNov 6, 2026what changed →
Valuation
What PGNY's price assumes
Progyny, Inc. trades at 32.0× earnings against 23.2× for the median Healthcare Plans name.
32.0
Trailing P/E · Healthcare Plans median 23.2 · 1.38× the Healthcare Plans median
- Price / sales
- 1.92
Price / sales · today's price, trailing year to Sep 30, 2026
- Free cash flow yield
- 7.0%
Free cash flow yield · Healthcare Plans median 6.7%
- Growth the price implies
- +1.2%
Growth the price implies · The price pays for +1.2% free cash flow growth a year for a decade; the business has delivered −3.4% a year over the last three.
Details›
- Price / booktoday's price, trailing year to Sep 30, 2026
- 6.20
- EV / EBITtoday's price, trailing year to Sep 30, 2026
- 17.9
- EV / salestoday's price, trailing year to Sep 30, 2026
- 1.69
- Healthcare median P/E497 names
- 27.1
- Healthcare Plans median P/E11 names
- 23.2
- Free cash flow, trailing twelve months
- $180M
- Market capitalisation73.6 million shares, counted Oct 31, 2026
- $2.57B
- 3-year revenue growth
- +9.0%
- 3-year free cash flow growth
- −3.4%
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Against its own past
Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.
On our screensFree cash flow yield of 5 to 30 percent